Alibaba Group Holding Ltd. Shares Slump Amid Regulatory Scrutiny

Alibaba Group Holding Ltd. faced a devastating day on the market as its shares plummeted lower after Chinese regulators set their sights on the tech giant in a fresh attack on the financial empire of billionaire Jack Ma. The turbulence sent shockwaves through the stock market, with several other tech companies also feeling the pinch. Despite this, some stocks showed resilience, including Moderna Inc, which received a significant boost after its coronavirus vaccine candidate won FDA approval.

Key Takeaways:

Alibaba Group Holding Ltd. shares slumped 6.02% in a single day, with Chinese regulators targeting the company in their latest attack on the financial empire of billionaire Jack Ma.
Moderna Inc received a significant boost after its coronavirus vaccine candidate won FDA approval, paving the way for the second vaccine candidate to combat the Covid-19 pandemic to win full FDA approval.
Ebay Inc, Zoom Video, Trip.com Group Ltd, Ulta Beauty Inc, Splunk Inc, Baidu Inc, Biogen Inc, Lululemon Athletica, and Regeneron Pharmaceuticals all experienced share price decreases, ranging from 0.77% to 6.02%.
Analysts expressed concern about valuation for Zoom Video and generated weak sales guidance for Ebay Inc, leading to share price drops.
Regeneron Pharmaceuticals shares spiked higher after receiving emergency approval for its coronavirus cocktail therapy from the U.S. Food & Drug Administration.
Al least five of the stocks mentioned have reported earnings within the last month, with Trip.com Group reporting a net income of $234 million in its third-quarter 2020 earnings.
Lululemon Athletica shares were falling 0.97% in pre-market trading despite reporting third-quarter results that topped analyst estimates for the period.
The biopharmaceutical companies Biogen and Sage Therapeutics have agreed to work together on Sage's depression drug.

Statistics:

Alibaba Group Holding Ltd. shares: decreased by 6.02% in a single day.
Moderna Inc shares: decreased by -6.02% on Thursday but gained after its coronavirus vaccine candidate won FDA approval.
Ebay Inc shares: decreased by -2.23%, with shares climbing 35% year to date.
Zoom Video shares: decreased by -2.05% after analysts expressed concern about valuation.
Trip.com Group Ltd shares: decreased by -1.96% after reporting a net income of $234 million in its third-quarter 2020 earnings.
Ulta Beauty Inc shares: decreased by -1.38% after reporting fiscal-third-quarter net income that fell 41% on 7.8% lower revenue.
Splunk Inc shares: decreased by -1.29% after reporting a wider fiscal-third-quarter loss on 11% lower revenue.
Baidu Inc shares: decreased by -1.27% despite jumping nearly 10% after reports that it is pondering making its own electric vehicles.
Biogen Inc shares: decreased by -0.95% after announcing an agreement with Sage Therapeutics to work together on Sage's depression drug.
Lululemon Athletica shares: decreased by -0.77% after reporting third-quarter results that topped analyst estimates for the period.
Regeneron Pharmaceuticals shares: decreased by -0.77% before spiking higher after receiving emergency approval for its coronavirus cocktail therapy from the U.S. Food & Drug Administration.

Sources:

"Moderna coronavirus vaccine wins FDA approval" (https://www.thestreet.com/investing/moderna-coronavirus-vaccine-wins-fda-advisory-panel-ok)
"eBay shares lower after analyst remarks about guidance" (https://www.thestreet.com/investing/ebay-shares-lower-after-analyst-remarks-about-guidance)
"Trip.com Group reports unaudited third-quarter 2020 financial" (https://investors.trip.com/news-releases/news-release-details/tripcom-group-reports-unaudited-third-quarter-2020-financial)
"Ulta Beauty lower after adjusted net beats revenue in line" (https://www.thestreet.com/investing/ulta-beauty-lower-after-adjusted-net-beats-revenue-in-line)
"Splunk shares lower after wider Q3 loss" (https://www.thestreet.com/investing/splunk-shares-lower-after-wider-q3-loss)
"Baidu bidu China electric vehicles" (https://www.thestreet.com/investing/baidu-bidu-china-electric-vehicles)
"Sage Biogen biib depression drug development" (https://www.thestreet.com/investing/sage-biogen-biib-depression-drug-development)
"Lululemon Q3 beat what Wall Street is saying" (https://www.thestreet.com/investing/lululemon-q3-beat-what-wall-street-is-saying)
"Regeneron shares spike on FDA approval for Covid-therapy" (https://www.thestreet.com/investing/regeneron-shares-spike-on-fda-approval-for-covid-therapy)